文献速递心外重症与机械循环支持

不同植入策略下左心室辅助装置患者健康相关生活质量的差异:INTERMACS登记分析

Differences in health-related quality of life by implant strategy: Analyses from the Interagency Registry for Mechanically Assisted Circulatory Support.
PubMed 文献 · J Heart Lung Transplant · 2019-11-06

本研究基于INTERMACS登记数据,比较了成人患者按术前植入策略分为 destino therapy(DT)、bridge to transplant(BTT)和bridge to candidacy(BTC)三组后,术前至术后2年健康相关生活质量(HRQOL)的变化。使用EQ-5D-3L和KCCQ-12问卷评估,结果显示所有组HRQOL随时间均有改善(p<0.05),但BTT组在术前KCCQ-12总体评分和2年EQ-5D-3L评分上显著更高,差异虽具统计学意义但未达临床重要差异。

要点

  • 无论植入策略如何,LVAD患者术后2年HRQOL均较术前改善。
  • BTT组在术前和2年时的部分HRQOL评分显著优于BTC和DT组。
  • 组间差异未达临床重要差异,但领域特异性差异存在。

核心结论

  • 无论植入策略如何,机械循环支持植入后2年内总体HRQOL普遍改善。
  • BTT组在术前KCCQ-12总体评分和2年EQ-5D-3L评分上显著更高,但差异未达临床重要差异。

研究设计与样本

  • 基于INTERMACS登记数据的回顾性分析,纳入接受初次连续流LVAD的成人患者,按术前策略分为DT(n=2,901)、BTT(n=2,209)和BTC(n=3,076)三组。
  • HRQOL数据在术前和术后2年通过EQ-5D-3L和KCCQ-12问卷收集,分析方法包括卡方检验、方差分析、配对t检验和一般线性随机效应模型。

主要发现

  • 配对t检验和一般线性随机效应模型显示所有组别HRQOL随时间改善(p值<0.05)。
  • 术前KCCQ-12总体评分:BTT组37.09,BTC组33.57,DT组33.56(p值<0.05)。
  • 2年EQ-5D-3L评分:BTT组75.18,BTC组72.27,DT组70.87(p值<0.05)。
  • HRQOL各领域评分也发现组间差异。

关键数值与推荐

  • BTT组术前KCCQ-12总体评分显著高于BTC和DT组(p<0.05)。
  • BTT组2年EQ-5D-3L评分显著高于BTC和DT组(p<0.05)。
  • 上述差异未达到临床重要差异。

临床怎么用

  • 临床中应认识到不同植入策略患者HRQOL改善趋势相似,但BTT患者部分评分可能更高。
  • 组间差异未达临床重要差异,解读HRQOL变化时需结合领域特异性结果。

局限性

  • 研究为观察性登记分析,可能存在混杂因素。
  • HRQOL问卷完成率随时间下降,可能引入偏倚。
  • 差异未达临床重要差异,需谨慎解释组间比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Midterm change in health-related quality of life (HRQOL) by left ventricular assist device (LVAD) implant strategy is unknown. The purpose of this study was to examine HRQOL by pre-operative implant strategy from before to 2 years after surgery. METHODS: Adult patients in the Interagency Registry for Mechanically Assisted Circulatory Support were stratified into 3 groups based on pre-implant device strategy: destination therapy (DT) (n = 2,901), bridge to transplant (BTT) (n = 2,209), and bridge to candidacy (BTC) (n = 3,076). HRQOL data were collected before and 2 years after surgery using the generic EQ-5D-3L survey and heart failure-specific Kansas City Cardiomyopathy Questionnaire (KCCQ-12). Statistical analyses included chi-square tests, analysis of variance, paired t-tests, and general linear random effects models. RESULTS: Between April 1, 2008 and June 30, 2013, 4,422 patients and 1,660 patients (majority males and ≥50 years) who received primary continuous flow LVADs completed baseline EQ-5D-3L and KCCQ-12 questionnaires, respectively, whereas 1,615 and 1,408 patients completed EQ-5D-3L and KCCQ-12 questionnaires at 2 years, respectively. Although paired t-tests and general linear random effects models showed that both heart failure-specific and generic HRQOL improved for all groups across time (p-values <0.05), some differences in HRQOL were found by implant strategy at baseline and 2 years, with a pattern favoring better functioning for patients with BTT. The BTT group reported significantly higher overall HRQOL pre-implant using the KCCQ-12 (BTT = 37.09, BTC = 33.57, and DT = 33.56) and at 2 years using the EQ-5D-3L (BTT = 75.18, BTC = 72.27, and DT = 70.87) (p-values <0.05), although these differences were not clinically important differences. Differences in HRQOL domains were also found. CONCLUSIONS: Using generic and heart failure-specific instruments, overall HRQOL generally improved from before to 2 years after mechanical circulatory support implant regardless of implant strategy, although important domain-specific differences by group were identified.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. White-Williams C, Fazeli PL, Kirklin JK, et al. Differences in health-related quality of life by implant strategy: Analyses from the Interagency Registry for Mechanically Assisted Circulatory Support. J Heart Lung Transplant. 2019. PMID: 31787446. doi:10.1016/j.healun.2019.10.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。